in-cosmetics Global 2018 will take place April 17-19 in Amsterdam and will include an educational program from Dr. Nava Dayan. For more information, contact Dayan at firstname.lastname@example.org, or visit the show site.
Natural compounds extracted from various plants parts present a challenge of standardization to their various components. In recent years, with the rapid and significant growth of this market formulators are presented with the difficulty of confirming the identity of the ingredients, their standardization profile, batch to batch consistency and prospective safety and efficacy profiles.
Adding to the struggle is confusion with regards to permitted claims for this market. Cosmetic manufacturers are phased with the questions: What does “natural” mean? Can a cosmetic product be 100% natural and organic? What are the consumer’s perception and expectations about “natural”?
Are there true “natural” preservatives, fragrances and emulsifiers? Can natural products be safe and effective?
This session brings a combination of experts in the field of natural chemical analysis experts and legal compliance. It will include guidance to industry professionals with regards to natural products sourcing, traceability, chemistry and identification as well as an overview claims and perspectives associated with this growing market.
Who should attend: Professionals in the cosmetic and personal care industry who develop raw materials and/or finished products with natural compounds in the areas of:
- Research and development
- Sales and marketing
- Safety and efficacy
- Supply chain
*Speaker's bio: Nava Dayan, Ph.D., Pharm, has 26 years of experience in the skin care segment, and has yielded more than 150 publication credits in numerous industry-respected journals and in four books. She has been awarded the In-Cosmetics Gold Award for innovation and commensurate recognition from the NYSCC and the CRS for excellence. Dr. Dayan is the owner of Dr. Nava Dayan L.L.C, a skin science and research consultancy serving the pharmaceutical, cosmetic, and personal care industries; dermal and transdermal. Dr. Dayan advises on product feasibility in skin care, composition of R&D plans covering efficacy and toxicology; planning, execution and data interpretation into claims, formulations, delivery for improved efficacy and attenuated toxicity. Sample areas of expertise include: drug-skin interaction, bio-markers (genomics and proteomics), skin/age related sensitivities, inflammatory skin disorders, innate immunity and biota. Contact: email@example.com.